Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011993 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Carolin M Lieber und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: Influenza A virus, Influenza, Human, Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Pre-existing or rapidly emerging resistance of influenza viruses to approved antivirals makes the development of novel therapeutics to mitigate seasonal influenza and improve preparedness against future influenza pandemics an urgent priority. We have recently identified the chain-terminating broad-spectrum nucleoside analog clinical candidate 4’-fluorouridine (4’-FlU) and demonstrated oral efficacy against seasonal, pandemic, and highly pathogenic avian influenza viruses in the mouse and ferret model. Here, we have resistance-profiled 4’-FlU against a pandemic A/CA/07/2009 (H1N1) (CA09). In vitro viral adaptation yielded six independently generated escape lineages with distinct mutations that mediated moderate resistance to 4’-FlU in the genetically controlled background of recombinant CA09 (recCA09). Mutations adhered to three distinct structural clusters that are all predicted to affect the geometry of the active site of the viral RNA-dependent RNA polymerase (RdRP) complex for phosphodiester bond formation. Escape could be achieved through an individual causal mutation, a combination of mutations acting additively, or mutations functioning synergistically. Fitness of all resistant variants was impaired in cell culture, and all were attenuated in the mouse model. Oral 4’-FlU administered at lowest-efficacious (2 mg/kg) or elevated (10 mg/kg) dose overcame moderate resistance when mice were inoculated with 10 LD 50 units of parental or resistant recCA09, demonstrated by significantly reduced virus load and complete survival. In the ferret model, invasion of the lower respiratory tract by variants representing four adaptation lineages was impaired. Resistant variants were either transmission-incompetent, or spread to untreated sentinels was fully blocked by therapeutic treatment of source animals with 4’-FlU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
- Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, United States of America.
- Emory Institute for Drug Development, Emory University School of Medicine, Atlanta, Georgia, United States of America.
ORCID-Profile: Richard K Plemper
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lieber, C. M., Kang, H. J., Aggarwal, M., Lieberman, N. A., Sobolik, E. B., Yoon, J. J., Natchus, M. G., Cox, R. M., Greninger, A. L., & Plemper, R. K. (2024). Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011993
Vancouver
Lieber CM, Kang HJ, Aggarwal M, Lieberman NA, Sobolik EB, Yoon JJ, et al. Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011993
BibTeX
@article{Lieber2024,
author = {Lieber, Carolin M and Kang, Hae-Ji and Aggarwal, Megha and Lieberman, Nicole A and Sobolik, Elizabeth B and Yoon, Jeong-Joong and Natchus, Michael G and Cox, Robert M and Greninger, Alexander L and Plemper, Richard K},
title = {Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011993}
}
EUVIMED